UpDoc debuts first FDA-cleared clinical AI platform, closes $18M seed round
UpDoc, a Palo Alto startup, won FDA clearance for what it calls the first Software as a Medical Device built on patient-facing large language models.
The company also closed an oversubscribed $18 million seed round and rolled out initial deployments at four of the nation's leading health systems.
Backers include the American Diabetes Association, Cathay Innovation, Eli Lilly, Mayo Clinic, Oxeon, Pear VC, Polaris Partners, and Section 32.
"AI doctors" are racing to market with little scrutiny, the company says, and UpDoc wants to position itself as the first FDA-cleared agentic platform that supports doctors rather than replacing them.
Its pitch lands amid a primary care crisis defined by limited patient access, rising costs, and clinician burnout.
UpDoc's platform embeds into provider workflows and integrates with electronic health records, letting clinicians deploy AI agents that extend care between scheduled visits.
The agents can adjust medications, order labs, and coordinate with care teams within physician-approved parameters.
AI that delivers care once requiring a licensed clinician carries clear safety and accountability risks.
UpDoc says its orchestration and safety architecture unifies clinical guidelines, patient context, physician governance, and EHR data to keep interventions traceable. But scaling autonomous clinical decisions across health systems will test that promise.
UpDoc's cap table reads like a who's who of healthcare incumbents — pharma giant Eli Lilly, the American Diabetes Association, and Mayo Clinic sit alongside specialist funds like Cathay Innovation and Pear VC, a mix that gives the early-stage startup both clinical credibility and distribution into the health systems it needs to scale. That backing matters for a company whose tagline centres on chronic disease management, where the diabetes-focused strategic investors stand to benefit directly from remote, AI-driven patient monitoring.
Read more: PR Newswire
Image credit: UpDoc
